PolyNovo Limited (FRA:MFJ)

Germany · Delayed Price · Currency is EUR

0.660

+0.005 (0.76%)

At close: Dec 5, 2025

-50.00% (1Y)

Market Cap	474.56M
Revenue (ttm)	71.85M
Net Income (ttm)	7.38M
Shares Out	n/a
EPS (ttm)	0.01
PE Ratio	64.33
Forward PE	56.34
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	0.660
Previous Close	0.655
Day's Range	0.660 - 0.660
52-Week Range	0.480 - 1.340
Beta	n/a
RSI	49.68
Earnings Date	Nov 24, 2025

About PolyNovo

PolyNovo Limited designs, manufactures, and sells biodegradable medical devices in Australia, New Zealand, the United States, the United Kingdom, Ireland, Singapore, India, and Hong Kong. The company offers NovoSorb Biodegradable Temporising Matrix, a dermal matrix for the regeneration of the dermis when lost through extensive surgery, trauma, or burn. It is also developing hernia devices for hernia repair and solution for ventral hernia and complex abdominal wall reconstruction; Beta Cell implant, a novel intracutaneous ectopic pancreas to tre... [Read more]

Industry Orthopedic, Prosthetic, and Surgical Appliances and Supplies

Founded 1998

Employees 301

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol MFJ

Full Company Profile

Financial Performance

In 2025, PolyNovo's revenue was 128.70 million, an increase of 24.67% compared to the previous year's 103.23 million. Earnings were 13.21 million, an increase of 151.17%.

Financial numbers in AUD Financial Statements

News

There is no news available yet.